1. Home
  2. NDMO vs PHAR Comparison

NDMO vs PHAR Comparison

Compare NDMO & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest

NDMO

Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest

HOLD

Current Price

$10.16

Market Cap

604.7M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.67

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NDMO
PHAR
Founded
N/A
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
604.7M
1.2B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
NDMO
PHAR
Price
$10.16
$12.67
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$38.33
AVG Volume (30 Days)
106.3K
10.4K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
N/A
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$9.57
$9.54
52 Week High
$10.82
$21.34

Technical Indicators

Market Signals
Indicator
NDMO
PHAR
Relative Strength Index (RSI) 41.26 31.19
Support Level $9.91 $11.43
Resistance Level $10.49 $17.41
Average True Range (ATR) 0.08 0.53
MACD -0.03 -0.09
Stochastic Oscillator 30.77 15.28

Price Performance

Historical Comparison
NDMO
PHAR

About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest

Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: